Albert David Ltd. benchmarking: Perfomance to industry peers

Financial

	Albert David	Medico Remedies	Jenburkt Pharma
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	0.84 %	n/a	0.29 %
Financials
5 yr Average ROE	11.47 %	13.93 %	18.49 %
5yr average Equity Multiplier	1.63	2.07	1.17
5yr Average Asset Turnover Ratio	0.62	1.49	0.88
5yr Avg Net Profit Margin	11.31 %	4.73 %	18.1 %
Price to Book	1.11	6.49	2.57
P/E	0.0	38.29	14.25
5yr Avg Cash Conversion Cycle	-77.77 Days	53.33 Days	-32.02 Days
Inventory Days	47.91 Days	48.95 Days	24.72 Days
Days Receivable	27.87 Days	129.15 Days	48.38 Days
Days Payable	140.35 Days	124.28 Days	82.6 Days
5yr Average Interest Coverage Ratio	93.73	11.55	87.2
5yr Avg ROCE	14.69 %	20.03 %	24.44 %
5yr Avg Operating Profit Margin	9.55 %	7.11 %	22.46 %
5 yr average Debt to Equity	0.02	0.26	0.02
5yr CAGR Net Profit	-4.92 %	31.26 %	14.21 %
5yr Average Return on Assets	7.03 %	6.88 %	15.8 %
Shareholdings
Promoter Holding	62.24 %	61.38 %	46.66 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.25 %	-11.96 %	0.93 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Albert David	Medico Remedies	Jenburkt Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Traded Goods 0 Manufactured Goods 0 Dermatology 0	Product Wise Break-Up Traded Goods 1.96 Dermatology 0 Pharmaceutical 0 Manufactured Goods 96.53 Others 1.51	Product Wise Break-Up Traded Goods 0 Dermatology 0 Pharmaceutical 0 Manufactured Goods 0 Others 100
Location Wise Break-Up	Location Wise Break-Up India 93.24 Rest of the World 6.76 Outside India 0	Location Wise Break-Up India 10.4 Rest of the World 0 Outside India 89.6	Location Wise Break-Up India 87.23 Rest of the World 12.56 Outside India 0 Others 0.21
Dosage Form Break-Up	Dosage Form Break-Up LVP – Large volume Parenteral 27.91 Syrup 21.16 Tablet 15.97 SVP – Small volume Parenteral 14.95 Capsule 9.65 Ointment 9.06 Others 1.3	-	-
Customer Wise Break-Up	Customer Wise Break-Up Non Government 98.36 Government 1.64	-	-